- News Home
10 April 2014 11:44 am ,
Vol. 344 ,
The Pyrenean ibex, an impressive mountain goat that lived in the central Pyrenees in Spain, went extinct in 2000. But a...
Tight budgets are forcing NASA to consider turning off one or more planetary science projects that have completed their...
Ebola is not a stranger to West Africa—an outbreak in the 1990s killed chimpanzees and sickened one researcher. But the...
In an as-yet-unpublished report, an international panel of geoscientists has concluded that a pair of deadly...
Tropical disease experts tried and failed before to eradicate yaws, a rare disfiguring disease of poor countries. Now,...
Since 2002, researchers have reported that agricultural communities in the hot and humid Pacific Coast of Central...
Balkan endemic kidney disease surfaced in the 1950s and for decades defied attempts to finger the cause. It occurred...
- 10 April 2014 11:44 am , Vol. 344 , #6180
- About Us
Senate Panel Gives NIH $100 Million Boost for 2013
12 June 2012 5:40 pm
A Senate panel today approved a modest $100 million raise for the National Institutes of Health (NIH) in the 2013 fiscal year which begins on 1 October. The 0.3% bump to a total of $30.723 billion is slightly better than the president's request for no increase but disappointing to the research community.
Given fiscal pressures in Congress, "we're appreciative of any increase," says Jennifer Zeitzer, director of legislative relations for the Federation of American Societies for Experimental Biology. Still, she says, "It's going to be difficult for people in the research community. One-hundred-million dollars doesn't go very far."
The NIH budget is part of a broader spending bill approved today by the Senate appropriations subcommittee on labor, health and human services, and education. A summary of the bill also mentions NIH's Cures Acceleration Network. This drug development effort would receive $40 million, four times its current funding (but $10 million below the president's request).
The Senate vote would continue a trend of stagnation in NIH's budget, biomedical research advocates say. They argue that NIH spending in recent years has not kept pace with so-called "biomedical inflation"—the rate at which research costs escalate each year—and estimate that the agency's budget is effectively 17% below what it was a decade ago.
The full Senate Appropriations Committee is scheduled to vote on the bill on Thursday. At that point more detail on specific programs may become available.